Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-12-01 Tax Withholding | 2022-12-02 8:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary | 541 | $7.75 | 27,924 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-02 5:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary | 25,000 | $0 | 28,465 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 4:01 pm | N/A 2032-02-11 | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Treasurer | 135,000 | $0 | 135,000 (Direct) | View |
| 2021-02-12 Option Award | 2021-02-16 6:00 pm | N/A 2031-02-12 | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Treasurer | 100,000 | $0 | 100,000 (Direct) | View |
| 2020-12-02 Ownership | 2020-12-02 9:12 pm | 2020-04-02 2030-04-02 | Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Treasurer | 0 | $0 | 506,011 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:32 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Meltz Mark A SVP General Counsel | 32,705 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:32 pm | N/A 2029-03-28 | Audentes Therapeutics Inc. | BOLD | Meltz Mark A SVP General Counsel | 104,000 | $0 | 0 (Direct) | View |
| 2019-12-12 Tax Withholding | 2019-12-16 6:04 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Meltz Mark A SVP General Counsel | 4,628 | $59.37 | 32,705 (Direct) | View |
| 2019-03-28 Option Award | 2019-04-01 5:54 pm | N/A 2029-03-28 | Audentes Therapeutics Inc. | BOLD | Meltz Mark A SVP General Counsel | 141,333 | $0 | 141,333 (Direct) | View |
| 2019-03-28 Ownership | 2019-04-01 5:53 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Meltz Mark A SVP General Counsel | 0 | $0 | 0 (Direct) | View |